DermaCompass - About the company
DermaCompass is an unfunded company based in Zurich (Switzerland), founded in 2014. It operates as a Skin analysis and diagnostic tool for dermatologists. DermaCompass has not raised any funding yet. The company has 298 active competitors, including 74 funded and 18 that have exited. Its top competitors include companies like PathAI, Aignostics and Aiforia.
Company Details
Skin analysis and diagnostic tool for dermatologists. the company has developed an app that acts as a practice assistant for detecting common skin diseases. The system can be used for decision support making processes, clinical activities, differential diagnoses, image analysis, medicine directory, and more.
- Website
- www.dermacompass.net/en/
- Email ID
- *****@dermacompass.net
Key Metrics
Founded Year
2014
Location
Zurich, Switzerland
Stage
Unfunded
Ranked
127th among 298 active competitors
Similar Companies
Sign up to download DermaCompass' company profile
DermaCompass's funding and investors
DermaCompass has not raised any funding rounds yet.
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
DermaCompass's Competitors and alternates
Top competitors of DermaCompass include PathAI, Aignostics and Aiforia. Here is the list of Top 10 competitors of DermaCompass, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | PathAI 2016, Boston (United States), Series C | Provider of digital pathology image management system for clinical labs | $255M | 72/100 | |
2nd | Aignostics 2018, Berlin (Germany), Series B | Developer of artificial intelligence software for biomedical image analysis applications | $53.9M | 64/100 | |
3rd | Provider of an AI and cloud-based, deep learning image analysis platform in all therapy areas | $23M | 64/100 | ||
4th | Nucle AI 2017, Chicago (United States), Series B | AI-assisted platform for image analysis | $60M | 62/100 | |
5th | Techcyte 2014, Orem (United States), Series B | Artificial intelligence (AI) based image analysis platform for pathologists | $50.4M | 62/100 | |
6th | Visiopharm 2001, Horsholm (Denmark), Acquired | Developer of a SaaS and AI-based digital pathology solutions for image analysis and workflow standardization | $26.3M | 60/100 | |
7th | Scopio Labs 2014, Tel Aviv (Israel), Series D | Developer of digital imaging platforms for hematology | $125M | 58/100 | |
8th | Skin Analytics 2012, London (United Kingdom), Series B | Provider of smartphone based skin cancer detection | $32.6M | 58/100 | |
9th | HistoIndex 2010, Singapore (Singapore), Series A | Provider of AI powered digital pathology platform for fibrosis analysis | $6.89M | 57/100 | |
10th | Fibronostics 2015, Orlando (United States), Series A | Non-invasive algorithm-based diagnostics | $14.5M | 55/100 | |
127th | DermaCompass 2014, Zurich (Switzerland), Unfunded | Skin analysis and diagnostic tool for dermatologists | - | - | 25/100 |
Looking for more details on DermaCompass's competitors? Click here to see the top ones
DermaCompass's Investments and acquisitions
DermaCompass has made no investments or acquisitions yet.
Reports related to DermaCompass
Here is the latest report on DermaCompass's sector:
Are you a Founder ?
FAQs about DermaCompass
Explore our recently published companies
- Fitpro-ai.co.uk - United Kingdom based, 2024 founded, Unfunded company
- Beplasticclever - United Kingdom based, Unfunded company
- CozyBerries - Malaysia based, 2020 founded, Unfunded company
- Home Tech Mart - India based, Unfunded company
- crm-appstore.com - Casa Grande based, 2012 founded, Unfunded company
- My Energy AI - United Kingdom based, Unfunded company
